Statins for Smith-Lemli-Opitz syndrome-Reference-Cited by-同舟云学术

Statins for Smith-Lemli-Opitz syndrome

Published:2022-11-14 Issue:11 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ballout Rami A¹²,Livinski Alicia³,Fu Yi-Ping⁴,Steiner Robert D⁵,Remaley Alan T¹

Affiliation:

1. Lipoprotein Metabolism Section, Translational Vascular Medicine Branch; National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH); Bethesda MD USA

2. Department of Pediatrics; University of Texas Southwestern (UTSW) Medical Center and Children’s Health; Dallas TX USA

3. Division of Library Services; National Institutes of Health Library, Office of Research Services; Bethesda Maryland USA

4. Office of Biostatistics Research; National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH); Bethesda MD USA

5. Marshfield Clinic Research Foundation; Marshfield Wisconsin USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference111 articles.

1. Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smith-Lemli-Opitz syndrome (SLOS);Chan;Pediatric Research,2009

2. Effects of cholesterol and simvastatin treatment in patients with Smith-Lemli-Opitz syndrome (SLOS);Haas;Journal of Inherited Metabolic Disease,2007

3. Plasma and thrombocyte levels of coenzyme Q10 in children with Smith-Lemli-Opitz syndrome (SLOS) and the influence of HMG-CoA reductase inhibitors;Haas;Biofactors,2008

4. Relation between biomarkers and clinical severity in patients with Smith-Lemli-Opitz syndrome;Oláh;European Journal of Pediatrics,2013

5. No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome;Roullet;Journal of Inherited Metabolic Disease,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LXR agonism for CNS diseases: promises and challenges;Journal of Neuroinflammation;2024-04-16